Get started
Author

Anneli Andersson

Observed names: ANNELI ANDERSSON, Andersson, Anneli
ORCID: 0000-0001-7881-4205
Observed ORCID: 0000-0001-7881-4205
OpenAlex ID: A5054171548
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)
2024 · Michele Vacca, Ioannis Kamzolas, et al. · Nature Metabolism · 274
PDF
Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis
2023 · Ferenc E Mózes, Jenny A Lee, et al. · The Lancet. Gastroenterology & hepatology · 231
PDF
Clinical Utility of Magnetic Resonance Imaging Biomarkers for Identifying Nonalcoholic Steatohepatitis Patients at High Risk of Progression: A Multicenter Pooled Data and Meta-Analysis
2021 · Anneli Andersson, Matt Kelly, et al. · Clinical Gastroenterology and Hepatology · 155
PDF
Decreases in cT1 and liver fat content reflect treatment-induced histological improvements in MASH
2024 · Naim Alkhouri, Cayden Beyer, et al. · Journal of Hepatology · 52
PDF
NAFLD and NASH biomarker qualification in the LITMUS consortium – Lessons learned
2022 · Daniel Guldager Kring Rasmussen, Quentin M. Anstee, et al. · Journal of Hepatology · 42
Comparison between magnetic resonance and ultrasound-derived indicators of hepatic steatosis in a pooled NAFLD cohort
2021 · Cayden Beyer, Chloe Hutton, et al. · PLoS ONE · 32
PDF
Quantitative MRI for Monitoring Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Test–Retest Repeatability Study
2024 · Cayden Beyer, Anneli Andersson, et al. · Journal of Magnetic Resonance Imaging · 17
PDF
High prevalence of MASLD in psoriasis and psoriatic arthritis assessed with multiparametric magnetic resonance imaging
2025 · Lija James, Charlie Diamond, et al. · Rheumatology · 12
PDF
Prospective validation of imaging and serum diagnostic biomarkers of steatohepatitis and fibrosis in MASLD: the LITMUS Imaging Study
2026 · Michael Pavlides, Yasaman Vali, et al. · Nature Medicine · 11
PDF
Head-to-head comparison among FAST, MAST, and multiparametric MRI-based new score in diagnosing at-risk MASH
2024 · Kento Imajo, Yusuke Saigusa, et al. · European Radiology · 11
Change in cT1 Following Interventions in MASLD: A Systematic Review and Meta-Analysis
2025 · Anneli Andersson, Rohit Loomba, et al. · Clinical Gastroenterology and Hepatology · 10
Decreases in liver cT1 accurately reflect histological improvement induced by therapies in MASH: a multi-centre pooled cohort analysis
2024 · Naim Alkhouri, Cayden Beyer, et al. · medRxiv · 1
PDF
Non-invasive tests in metabolic dysfunction-associated steatotic liver disease: the LITMUS prospective multicentre diagnostic accuracy study
2026 · Yasaman Vali, Kristy Wonders, et al. · The Lancet
Impact of disease-modifying therapies in adults with concomitant psoriatic and metabolic liver disease with integrated immunoprofiling
2026 · Shannon Gunawardana, Lija James, et al. · medRxiv
PDF
FRI-479 Liver transplant recipients experiencing biliary complications show elevation in quantitative magnetic resonance cholangiopancreatography metrics during monitoring
2026 · Tom Davis, Anneli Andersson, et al. · Journal of Hepatology
Periductal iron-corrected T1 is a predictor of adverse outcomes in large-duct primary sclerosing cholangitis
2026 · Emmanuel A. Selvaraj, Ahmed Ba-Ssalamah, et al. · BMC Medical Imaging
Periductal iron-corrected T1 is a predictor of adverse outcomes in large-duct primary sclerosing cholangitis
2026 · Selvaraj, Emmanuel A., Ba-Ssalamah, Ahmed, et al. · Figshare
Additional file 1 of Periductal iron-corrected T1 is a predictor of adverse outcomes in large-duct primary sclerosing cholangitis
2026 · Selvaraj, Emmanuel A., Ba-Ssalamah, Ahmed, et al. · Figshare
1740-P: Weight Loss-Related Changes in MRI-Derived Measures of Body Composition and Liver Health—A Large-Scale Analysis from the UK Biobank
2025 · MAGDALENA NOWAK, TIM PAGLIARO, et al. · Diabetes
WED-383 Change in cT1 following interventions in metabolic dysfunctionassociated steatotic liver disease: a systematic review and metaanalysis
2025 · Anneli Andersson, Rohit Loomba, et al. · Journal of Hepatology
WED-478 Novel multiparametric MRI imaging predicts histologic response in resmetirom versus placebo in the multicentre, international, Maestro NASH phase 3 trial
2025 · Andrea Dennis, Hang Zhang, et al. · Journal of Hepatology
WED-488 Weight loss-related changes in MRI-derived measures of body composition and liver health: a large-scale analysis from the UK biobank
2025 · Magdalena Nowak, Tim Pagliaro, et al. · Journal of Hepatology
Tu1594 IDENTIFICATION OF AT-RISK NONALCOHOLIC STEATOHEPATITIS IN LEAN INDIVIDUALS WITH MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING BIOMARKER, CORRECTED T1
2023 · Naim Alkhouri, Carlos Duncker, et al. · Gastroenterology
PDF
Multiparametric MRI biomarker corrected T1 as a prognostic marker in chronic liver disease
2022 · Naim Alkhouri, Cayden Beyer, et al. · Journal of Hepatology
Works count: 24
Citation count: 848
H-index: 10
I10-index: 11
Year
Topic
Type